Review decisions

Showing 2120 results of 2256 total
Summary Basis of Decision for Saphris ™
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00133
Product Type: Drug
Control Number: 127427
DIN(s): 02374803, 02374811
Manufacturer: Merck Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2009-11-12
Issued / Original Publication Date: 2012-02-14
Updated Date: 2011-10-07
Summary Basis of Decision for Vpriv ™
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00310
Product Type: Drug
Control Number: 132604
DIN(s): 02357119
Manufacturer: Shire Human Genetic Therapies, Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2009-10-21
Issued / Original Publication Date: 2011-02-25
Updated Date: 2010-10-01
Summary Basis of Decision for Colesevalam hydrochloride (Lodalis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00031
Product Type: Drug
Control Number: 133463
DIN(s): 02373955
Manufacturer: Genzyme Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2009-10-09
Issued / Original Publication Date: 2012-01-27
Updated Date: 2011-09-22
Summary Basis of Decision for Uloric ™
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00158
Product Type: Drug
Control Number: 129969
DIN(s): 02357380
Manufacturer: Takeda Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2009-08-31
Issued / Original Publication Date: 2010-12-21
Updated Date: 2010-09-22
Summary Basis of Decision for Visanne ®
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00306
Product Type: Drug
Control Number: 132174
DIN(s): 02374900
Manufacturer: Bayer Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2009-08-21
Issued / Original Publication Date: 2012-02-14
Updated Date: 2011-10-12
Summary Basis of Decision for Arepanrix ™   H1N1 (AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00010
Product Type: Drug
Control Number: 132070
Manufacturer: ID Biomedical doing business in Canada as GlaxoSmithKline Biologicals North America
Submission Type: New Drug Submission
Date Filed / Submission Date: 2009-08-18
Issued / Original Publication Date: 2010-05-11
Updated Date: 2009-10-21
Summary Basis of Decision for Dexilant ™
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00042
Product Type: Drug
Control Number: 129674
DIN(s): 02354950, 02354969
Manufacturer: Takeda Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2009-08-11
Issued / Original Publication Date: 2010-11-29
Updated Date: 2010-07-22
Summary Basis of Decision for Daxas ™
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00041
Product Type: Drug
Control Number: 127683
DIN(s): 02359456
Manufacturer: Nycomed Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2009-08-10
Issued / Original Publication Date: 2011-03-08
Updated Date: 2010-11-23
Summary Basis of Decision for Kuvan ™
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00083
Product Type: Drug
Control Number: 128151
DIN(s): 02350580
Manufacturer: Biomarin Pharmaceutical Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2009-07-30
Issued / Original Publication Date: 2010-08-12
Updated Date: 2010-04-30
Summary Basis of Decision for Flumist ®
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00064
Product Type: Drug
Control Number: 129379
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2009-07-21
Issued / Original Publication Date: 2011-01-10
Updated Date: 2010-06-22

Displaying 2111 - 2120 of 2256 | Page 212 of 226
Report a problem or mistake on this page
Please select all that apply:
Date modified: